Pages that link to "Q70736024"
Jump to navigation
Jump to search
The following pages link to High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer (Q70736024):
Displaying 50 items.
- Whither high-dose chemotherapy in breast cancer? (Q24801121) (← links)
- Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver" (Q26866293) (← links)
- (Q28366611) (← links)
- Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center (Q30588208) (← links)
- Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research). (Q30696719) (← links)
- Problems with public reporting of cancer quality outcomes data (Q30823461) (← links)
- Much Ado About Not ... Enough Data: High-Dose Chemotherapy With Autologous Stem Cell Rescue for Breast Cancer (Q32125096) (← links)
- Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation (Q33348201) (← links)
- Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments (Q33560827) (← links)
- Pharmacoeconomic considerations in treating patients with acute leukaemia (Q33648362) (← links)
- High dose therapy of breast cancer: current status (Q33706206) (← links)
- Autologous stem-cell transplantation for solid tumors in adults (Q33769684) (← links)
- Adjuvant systemic therapy for primary breast cancer (Q33779184) (← links)
- High-dose chemotherapy: is it standard management for any common solid tumor? (Q33787443) (← links)
- Stem-cell transplant preparative regimens (Q33788170) (← links)
- Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer (Q33810287) (← links)
- High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study (Q33893535) (← links)
- Multidisciplinary care for patients with breast cancer (Q33932014) (← links)
- Overview of autologous stem cell transplantation. (Q34038567) (← links)
- Randomized trials of high dose chemotherapy for breast cancer. (Q34183739) (← links)
- Methodologic guidelines for the design of high-dose chemotherapy regimens (Q34379226) (← links)
- High-dose chemotherapy for solid tumors: results of the EBMT. (Q34539512) (← links)
- High-dose chemotherapy in advanced breast cancer (Q34539518) (← links)
- Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer (Q34558250) (← links)
- Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue (Q34736588) (← links)
- High-dose chemotherapy and stem cell support for breast cancer: where are we now? (Q34786659) (← links)
- Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer (Q34886445) (← links)
- Autologous peripheral blood stem cells (PBSC) in breast cancer (Q34913784) (← links)
- Recent advances in the systemic therapy of breast cancer. (Q35052282) (← links)
- High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials. (Q35065084) (← links)
- Evidence-based indications for postmastectomy irradiation (Q35182953) (← links)
- High-dose chemotherapy in breast cancer (Q35871127) (← links)
- Stem-cell transplantation for the treatment of advanced solid tumors (Q35887819) (← links)
- Cardiac toxicity of high-dose chemotherapy (Q35949084) (← links)
- Continuous 5-fluorouracil in the treatment of breast cancer (Q36079497) (← links)
- Abandonment of High‐Dose Chemotherapy/Hematopoietic Cell Transplants for Breast Cancer Following Negative Trial Results (Q36085529) (← links)
- High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study (Q36115468) (← links)
- High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration (Q36420168) (← links)
- Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer. (Q36528656) (← links)
- Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer (Q36612561) (← links)
- Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer (Q36619123) (← links)
- First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). (Q36619863) (← links)
- Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. (Q36894993) (← links)
- Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience (Q37340528) (← links)
- Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources (Q37361816) (← links)
- High-dose chemotherapy of cyclophosphamide, thiotepa and carboplatin (CTCb) followed by autologous stem-cell transplantation as a consolidation for breast cancer patients with 10 or more positive lymph nodes: a 5-year follow-up results (Q37447014) (← links)
- Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years? (Q37730641) (← links)
- There is insufficient evidence to recommend lens extraction as a treatment for primary open‐angle glaucoma: an evidence‐based perspective (Q37888793) (← links)
- The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells (Q40397505) (← links)
- The use of anthracyclines in the adjuvant treatment of breast cancer (Q40471815) (← links)